Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Grill

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
JAMA Neurology|December 1, 2025
Blood Tests for Alzheimer Disease-What to Do With the Holy GrailJoshua D Grill
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 13, 2023
Remaining Questions in a Brave New World of Alzheimer's Disease CareJoshua D Grill
Alzheimer'S & Dementia (New York, N. Y.)|April 26, 2017
Recruiting to preclinical Alzheimer's disease clinical trials through registriesJoshua D Grill
JAMA Network Open|December 1, 2025
Disclosing Alzheimer Biomarkers to Motivate Brain Health BehaviorsJoshua D Grill
Alzheimer Disease and Associated Disorders|October 21, 2015
Consider the Source: The Implications of Informant Type on Outcome AssessmentsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|February 1, 2025
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: the need for rigorJoshua D Grill, Daniel Gillen
Nature Reviews. Neurology|July 16, 2021
The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDAJason Karlawish, Joshua D Grill
JAMA Neurology|June 6, 2022
Disclosing Alzheimer Disease Biomarker Results to Research ParticipantsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|December 22, 2010
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trialsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|December 8, 2017
Study partners should be required in preclinical Alzheimer's disease trialsJoshua D Grill, Jason Karlawish
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
JAMA Neurology|December 1, 2025
Blood Tests for Alzheimer Disease-What to Do With the Holy GrailJoshua D Grill
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 13, 2023
Remaining Questions in a Brave New World of Alzheimer's Disease CareJoshua D Grill
Alzheimer'S & Dementia (New York, N. Y.)|April 26, 2017
Recruiting to preclinical Alzheimer's disease clinical trials through registriesJoshua D Grill
JAMA Network Open|December 1, 2025
Disclosing Alzheimer Biomarkers to Motivate Brain Health BehaviorsJoshua D Grill
Alzheimer Disease and Associated Disorders|October 21, 2015
Consider the Source: The Implications of Informant Type on Outcome AssessmentsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|February 1, 2025
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: the need for rigorJoshua D Grill, Daniel Gillen
Nature Reviews. Neurology|July 16, 2021
The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDAJason Karlawish, Joshua D Grill
JAMA Neurology|June 6, 2022
Disclosing Alzheimer Disease Biomarker Results to Research ParticipantsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|December 22, 2010
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trialsJoshua D Grill, Jason Karlawish
Alzheimer'S Research & Therapy|December 8, 2017
Study partners should be required in preclinical Alzheimer's disease trialsJoshua D Grill, Jason Karlawish
Pageof 17